U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 214264
Company: ZYDUS PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB No No
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 22MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/19/2021 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214264Orig1s000ltr.pdf

TOFACITINIB CITRATE

TABLET, EXTENDED RELEASE;ORAL; EQ 11MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 218462 AUROBINDO PHARMA LTD
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 219442 BIOCON PHARMA
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 216001 SINOTHERAPEUTICS INC
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 214264 ZYDUS PHARMS
XELJANZ XR TOFACITINIB CITRATE EQ 11MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 208246 PFIZER

TABLET, EXTENDED RELEASE;ORAL; EQ 22MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
TOFACITINIB CITRATE TOFACITINIB CITRATE EQ 22MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 214264 ZYDUS PHARMS
XELJANZ XR TOFACITINIB CITRATE EQ 22MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 208246 PFIZER
Back to Top